Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults

Background Kaposi's sarcoma remains the most common cancer in Sub‐Saharan Africa and the second most common cancer in HIV‐infected patients worldwide. Since the introduction of highly active antiretroviral therapy (HAART), there has been a decline in its incidence. However, Kaposi's sarcoma continues to be diagnosed in HIV‐infected patients. Objectives To assess the added advantage of chemotherapy plus HAART compared to HAART alone; and the...